Vertaling van "disease " (Frans → Nederlands) :

TERMINOLOGIE

virus Borna disease
Borna disease-virus

virus Lymphocystis disease
Lymfocytaire virusziekte

rippling muscle disease
rippling muscle-ziekte

virus Nairobi sheep disease
Nairobi sheep disease-virus

virus Epizootic hemorrhagic disease, New Jersey
epizootisch hemorrhagische ziekte, New Jersey-virus

virus Jembrana disease
Jembrana-virusziekte

virus Border disease
Border disease-virus

virus Bovine mucosal disease
bovien mucosal disease-virus

rippling muscle disease avec myasthenia gravis
immuun-gemedieerde golvende spierziekte

IN-CONTEXT TRANSLATIONS

tombant sous un des chapitres suivants du ‘International Classification of Diseases’: 001-139 Certain infectious and parasitic diseases, II 140-239 Neoplasms, III 240-279 Endocrine, nutritional and metabolic diseases and Immunity disorders, IV 280-289 Diseases of the blood and blood-forming organs, VI 320-359 Diseases of the nervous system, VII 390-459 Diseases of the circulatory system, VIII 460-519 Diseases of the respiratory system, IX 520-579 Diseases of the digestive system, X 580-629 Diseases of the genitourinary system, XII 680-709 Diseases of the skin and subcutaneous tissue, XIII 710-739 Diseases of the musculoskeletal system and connective tissue, XVI 780-799 Symptoms, and ill defined conditions, XVII 800-999 Injury, poisoning.
de volgende hoofdstukken van de ‘International Classification of Diseases’: 001-139 Certain infectious and parasitic diseases, II 140-239 Neoplasms, III 240-279 Endocrine, nutritional and metabolic diseases and Immunity disorders, IV 280-289 Diseases of the blood and blood-forming organs, VI 320-359 Diseases of the nervous system, VII 390- 459 Diseases of the circulatory system, VIII 460-519 Diseases of the respiratory system, IX 520-579 Diseases of the digestive system, X 580-629 Diseases of the genitourinary system, XII 680-709 Diseases of the skin and subcutaneous tissue, XIII 710-739 Diseases of the musculoskeletal system and connective tissue, XVI 780-799 Symptoms, and ill defined conditions, XVII 800-999 Injury, poisoning.

Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease perioperative risks ii . NICE Minor surgery: ASA I : not indicated ASA II : consider > 40 y if respiratory or CV disease ASA III : consider if respiratory or CV disease Intermediate surgery: ASA I : not indicated ASA II : consider if respiratory or CV disease (renal > 60y) ASA III : consider if respiratory, CV or renal disease Major surgery: ASA I : consider > 60 ASA II : consider if respiratory, CV or renal disease ASA III : consider if respiratory, CV or renal disease
Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease

Auteurs : Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Institut Scientifique de Santé Publique), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Mutualité chrétienne), Michael Callens (Mutualité chrétienne), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).
Auteurs: Philippe Beutels (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Wetenschappelijk Instituut Volksgezondheid), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Christelijke Mutualiteit), Michael Callens (Christelijke Mutualiteit), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).

oral glucose tolerance test Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and Prevention US Preventive Services Task Force ultrasound scan urinary tract infection Veneral Disease Research Laboratory (test for syphilis) vaginal examination Vlaamse Organisaties van Vroedvrouwen Vlaamse Vereniging voor Obstetrie en Gynaecologie Wereldgezondheidsorganisatie World Health Organization weighted mean difference Wetenschappelijke Vereniging van Vlaamse Huisartsen
Office de la Naissance et de l'Enfance odds ratio over-the-counter papanicolou plasma protein A polymerase chain reaction Public Health Laboratory Service pregnancy-induced hypertension proton pump inhibitor positive predictive value premature rupture of membranes routine antenatal anti-D prophylaxis Royal College of Obstetricians and Gynaecologists randomised controlled trial eferences rhesus D recombinant immunoblot assay Rijksinstituut voor Ziekte- en Invaliditeitsverzekering ribonucleic acid random plasma glucose rapid plasmin reagin test relative risk reagent strip testing standard deviation single entry two step symphysis-fundal height small for gestational age Scottish Intercollegiate Guidelines Network sexueel overdraagbare aandoening Society of Obstetricians and Gynaecologists of Canada symphysis pubis dysfunction Treponema pallidum haemagglutination assay thyroïd stimulating hormone nconjugated oestriol United Kingdom United States Centers for Disease Control and

En Belgique, on utilise surtout le système de codific ation international WHO ICD (International Classification of Diseases) pour la rédaction de rapports et de statistiques.
Voor rapporterings- en statistiekdoeleinden wordt in België voornamelijk gebruik gemaakt van het internationale WHO-codificatiesysteem ICD (International Classification of Diseases).

1. Le “Vaccine & Infectious Disease Institute” (VAXINFECTIO) de l’université d’Anvers réalise, à l’heure actuelle, pour les besoins du service public fédéral Santé publique, Sécurité de la chaîne alimentaire et Environnement, une étude relative à l’effet des campagnes belges d’information sur les antibiotiques sur la consommation d’antibiotiques dans le secteur ambulatoire depuis 2001.
1. Het “Vaccine & Infectious Disease Institute” (VAXINFECTIO) van de Universiteit Antwerpen verricht momenteel, ten behoeve van de federale overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu, een onderzoek naar het effect van de Belgische antibioticacampagnes op het antibioticagebruik in de ambulante praktijk sinds 2001.

- il s'agit d'un médicament de la liste suivante de codes ATC: R01 Nasal preparations, R03 Drugs for obstructive airway diseases, R05 Cough and cold preparations; R06 Antihistamines for systemic use, R07 Other respiratory system products, S01G Decongestants and antiallergics.
- het betreft een geneesmiddel uit volgende lijst ATC codes: R01 Nasal preparations, R03 Drugs for obstructive airway diseases, R05 Cough and cold preparations; R06 Antihistamines for systemic use, R07 Other respiratory system products, S01G Decongestants and antiallergics.

Des exemples sont ICD-O (International Classification of Diseases for Oncology), utilisé par le registre cancer et ICPC-2 (International Classification of Primary Care), qui est une codification spécifique à la médecine générale.
Voorbeelden hiervan zijn ICD-O (International Classification of Diseases for Oncology) die gebruikt wordt door het Kankerregister. ICPC-2 (International Classification of Primary Care) is een codering die specifiek is voor de huisartsgeneeskunde.

General Affairs Council meeting, Brussels, September 13th 2010”, [http ...]
General Affairs Council meeting, Brussels, September 13th 2010”, [http ...]

Le système européen de surveillance de la grippe est placé sous la responsabilité de l’ECDC (European Center for Disease prevention and Control) et de l’Organisation Mondiale de la Santé pour l’Europe.
Het Europees systeem voor de bewaking van de griep staat onder de verantwoordelijkheid van de ECDC (European Center for Disease prevention and Control) en de Wereldgezondheidsorganisatie voor Europa.